Cangrelor in percutaneous coronary interventions: advances in evidence, clinical applications, and future directions [0.03%]
冠状动脉介入治疗中的坎格瑞洛：证据、临床应用及发展方向
Vincenzo De Sio,Felice Gragnano,Arturo Cesaro et al.
Vincenzo De Sio et al.
Introduction: Cangrelor is the only parenteral P2Y12 receptor antagonist currently recommended for the prevention of periprocedural thrombotic complications in P2Y12 inhibitor-naïve patients undergoing percutaneous coron...
High apoB/apoA-1 ratio is a strong risk predictor of major adverse cardio- and cerebrovascular events part 2: a review basis for updating guidelines [0.03%]
高apoB/apoA-1比值是重大不良心血管和脑血管事件的强风险预测因素（第二部分）：更新指南依据的回顾性研究
Göran Walldius
Göran Walldius
Introduction: Hypercholesterolemia and other dyslipidemias are common risk factors for cardiovascular diseases (CVD) and development of atherosclerosis. International guidelines recommend LDL-C, non-HDL-C and apoB under s...
High apoB/apoA-1 ratio is a strong risk predictor of major adverse cardio- and cerebrovascular events part 1: a review basis for updating guidelines [0.03%]
高apoB/apoA-1比值是主要不良心血管和脑血管事件的强风险预测因素（一）：更新指南的基础
Göran Walldius
Göran Walldius
Introduction: Hypercholesterolemia and other dyslipidemias are common risk factors for cardiovascular diseases (CVD) and development of atherosclerosis. International guidelines recommend LDL-C, non-HDL-C and apoB under s...
The association between the compliance of prescriptions with treatment guidelines and long-term survival after acute coronary syndrome: results from the ERICO study [0.03%]
急性冠脉综合征后依从治疗指南的处方与长期生存之间的关联：ERICO研究结果
Rafael C O Santos,Isabela M Bensenor,Paulo A Lotufo et al.
Rafael C O Santos et al.
Background: Compliance of prescriptions with treatment guidelines (CPTG) after an acute coronary syndrome (ACS) is poorly studied. We studied CPTG index levels in ERICO cohort over three years and its association with lon...
What is the importance of understanding heart disease causes in nonischemic and ischemic cardiomyopathy for left ventricular thrombus patients? [0.03%]
了解非缺血性和缺血性心肌病的心脏疾病原因对左心室血栓患者的重要性是什么？
Masashi Fujino,Teruo Noguchi
Masashi Fujino
Clinical utility of platelet FcγRIIa as a cardiovascular risk marker in patients in acute myocardial infarction [0.03%]
急性心肌梗死患者中血小板FcγRIIa的临床效用作为心血管风险标志物
Ahmad Hallak,Mark B Effron
Ahmad Hallak
How can clinicians reduce the risk of and manage severe aortic valve regurgitation manifesting as cardiogenic shock? [0.03%]
临床医生如何降低风险并管理表现为心源性休克的重度主动脉瓣反流？
Ana Paula Tagliari,Adriano Nunes Kochi
Ana Paula Tagliari
Introduction: Severe aortic regurgitation is a progressive condition that can lead to cardiogenic shock, a life-threatening emergency associated with high morbidity and mortality. ...
Direct oral anticoagulants versus vitamin K antagonists in concurrent hypertrophic cardiomyopathy and atrial fibrillation: a meta-analysis [0.03%]
直接口服抗凝药与维生素K拮抗剂联合肥厚型心肌病和房颤治疗的Meta分析研究：对患者结局的影响
Max Aboutorabi,Mahmood Ahmad,Kiran Flora et al.
Max Aboutorabi et al.
Introduction: Twenty to twenty-five percent of patients with hypertrophic cardiomyopathy (HCM) have concurrent atrial fibrillation (AF). It is unclear whether direct oral anticoagulants (DOAC) are a safe and effective alt...
Impact of ventricular arrhythmia in patients with sarcoidosis: an analysis of the National Readmission Database [0.03%]
美国再入院数据库中 sarcoidosis 患者室性心律失常的预后影响分析
Sri Nuvvula,Nikolaos Kakouros,Shehabaldin Alqalyoobi et al.
Sri Nuvvula et al.
Background: The impact of ventricular arrhythmia in patients with sarcoidosis has not been well studied. Our objective was to determine the association of ventricular arrhythmia with clinically relevant outcomes in sarcoi...
How could ultraslow low-dose thrombolytic infusion regimes affect high thrombosis resolution rates in prosthetic valve thrombosis? [0.03%]
超慢低剂量溶栓输注方案如何影响人工瓣膜血栓高溶解率？
Sabahattin Gündüz,Mehmet Ozkan
Sabahattin Gündüz
Introduction: Prosthetic valve thrombosis (PVT) is a life-threatening complication of mechanical heart valve replacement. Management has evolved over decades, from urgent surgical intervention to thrombolytic therapy. Rec...